Over 25% of the children taking dinutuximab (also called Unituxin) experienced negative side effects; the drug carries black box warnings for neurotoxicity and infusion reactions.
Over 25% of the children taking dinutuximab (also called Unituxin) experienced negative side effects; the drug carries black box warnings for neurotoxicity and infusion reactions.